Next 10 |
2024-05-03 10:54:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galecto (NASDAQ: GLTO ) just reported results for the first quarter of 2024. Galecto reported earnings per share of -20 cents. This was above the analyst estimate for EPS ...
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced that the first patient has been enrolled in an investigator-initiated Phase 2 trial to evaluate GB1...
Morgan Advanced Materials Plc (MCRUF) is expected to report for Q4 2023 Security Federal Corp (SFDL) is expected to report for Q1 2024 Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q1 2024 OMV AG (OMVJF) is expected to report $1.91 for Q1 2024 Pola Orbis ...
2024-03-15 13:53:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galecto (NASDAQ: GLTO ) just reported results for the fourth quarter of 2023. Galecto reported earnings per share of -22 cents. This was above the analyst estimate for EPS...
2023-12-21 16:40:39 ET More on Galecto Galecto reduces workforce by 70%, explores potential strategic alternatives Seeking Alpha’s Quant Rating on Galecto Historical earnings data for Galecto Financial information for Galecto For further detail...
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced positive topline results from a Phase 2a trial of GB2064 for the treatment of myelofibrosis (the &...
Galecto Inc. (GLTO) is expected to report $-0.47 for Q3 2023
BOSTON, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today presented a poster with new and encouraging clinical data, including two additional partial responders, from...
2023-09-27 12:18:23 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ShiftPixy Inc (NASDAQ: PIXY), SciSparc Ltd (NASDAQ: SPRC), Galecto Inc (NASDAQ: GLTO), American Strate...
2023-09-27 09:55:35 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ShiftPixy Inc (NASDAQ: PIXY), Galecto Inc (NASDAQ: GLTO), Cardiff Oncology Inc (NASDAQ: CRDF), American Strat...
News, Short Squeeze, Breakout and More Instantly...
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced that the first patient has been enrolled in an investigator-initiated Phase 2 trial to evaluate GB1...
Morgan Advanced Materials Plc (MCRUF) is expected to report for Q4 2023 Security Federal Corp (SFDL) is expected to report for Q1 2024 Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q1 2024 OMV AG (OMVJF) is expected to report $1.91 for Q1 2024 Pola Orbis ...